MRUS Merus N.V.

11.54
+0.18  (+2%)
Previous Close 11.36
Open 11.38
Price To Book 2.74
Market Cap 262545005
Shares 22,750,867
Volume 15,566
Short Ratio
Av. Daily Volume 48,663

Drug Information

Drug catalyst information is displayed when you hover over the stage bar graph.

Phase 2 update due 2H 2019.
MCLA-128
Breast cancer - HER2-positive MBC and ER+/HER2-low MBC
Noted December 27, 2018 that NSCLC cohort enrolment is ongoing but will discontinue endometrial and ovarian cohorts.
MCLA-128
Gastric cancer, non-small cell lung cancer
Phase 1 readouts due 2H 2019.
MCLA-117
Acute Myeloid Leukemia
Phase 1 emerging data due YE 2019.
MCLA-158
Colorectal cancer